Full View

Adverse drug reactions of botulinum neurotoxin type A in children with cerebral palsy: a pharmaco‐epidemiological study in VigiBase

J Montastruc, P Marque, F Moulis… - … Medicine & Child …, 2017 - Wiley Online Library
Aim The aim of this study was to assess the risk of adverse drug reactions (ADR s) with
botulinum neurotoxin type A (Bo NT‐A) in children with cerebral palsy (CP) using the World …
被引用次数：36 相关文章

Adverse drug reactions of botulinum neurotoxin type A in children with cerebral palsy: a pharmaco-epidemiological study in VigiBase.

J Montastruc, P Marque, F Moulis, V Bourg… - … Medicine and Child …, 2016 - europepmc.org
Aim The aim of this study was to assess the risk of adverse drug reactions (ADRs) with
botulinum neurotoxin type A (BoNT-A) in children with cerebral palsy (CP) using the World …

Adverse drug reactions of botulinum neurotoxin type A in children with cerebral palsy: a pharmaco-epidemiological study in VigiBase

J Montastruc, P Marque, F Moulis… - … medicine and child …, 2017 - pubmed.ncbi.nlm.nih.gov
Aim The aim of this study was to assess the risk of adverse drug reactions (ADRs) with
botulinum neurotoxin type A (BoNT-A) in children with cerebral palsy (CP) using the World …

Adverse drug reactions of botulinum neurotoxin type A in children with cerebral palsy: a pharmaco‐epidemiological study in VigiBase

J Montastruc, P Marque, F Moulis, V Bourg… - … Medicine & Child …, 2017 - infona.pl
Aim The aim of this study was to assess the risk of adverse drug reactions (ADR s) with
botulinum neurotoxin type A (Bo NT‐A) in children with cerebral palsy (CP) using the World …

Adverse drug reactions of botulinum neurotoxin type A in children with cerebral palsy: a pharmaco-epidemiological study in VigiBase.

J Montastruc, P Marque, F Moulis, V Bourg, V Lambert… - 2017 - cabidigitallibrary.org
Aim: The aim of this study was to assess the risk of adverse drug reactions (ADRs) with
botulinum neurotoxin type A (BoNT-A) in children with cerebral palsy (CP) using the World …